MedTrace Logo

Psychological Effects of 8 Weeks Supplementation With Sceletium Tortuosum Extract

NCT05471804 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2022-07-25

No results posted yet for this study

Summary

This study employs a randomized controlled trial to test the cognitive enhancing and stress relieving potential of the product Zembrin® in healthy adults when consumed over an 8 week period.

Conditions

  • Cognitive Change
  • Stress, Psychological

Interventions

DIETARY_SUPPLEMENT

Sceletium tortuosum

Zembrin® is a proprietary low-alkaloid extract of Sceletium tortuosum, often consumed by healthy humans in order to decrease anxiety and stress and improve cognitive function under stressful situations

Sponsors & Collaborators

  • HG&H Pharmaceuticals

    collaborator UNKNOWN

  • Northumbria University

    lead OTHER

Principal Investigators

  • Emma Wightman, PhD · Northumbria University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-18
Primary Completion
2022-11-01
Completion
2022-11-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05471804 on ClinicalTrials.gov